Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment

Press/Media: Expert Comment

PeriodNov 3 2021

Media coverage

1

Media coverage

  • TitleParthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment
    Media name/outletFirstWord Pharma
    Country/TerritoryUnited States
    Date11/3/21
    URLwww.firstwordpharma.com/node/1876726
    PersonsRong Li
View all 1
View less